Revolution Medicines, Inc. (NASDAQ:RVMD) Given Consensus Rating of “Buy” by Analysts
Shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) have received an average rating of “Buy” from the twelve research firms that are currently covering the stock, MarketBeat reports. Twelve research analysts have rated the stock with a buy rating. The average 1-year target price among brokerages that have updated their coverage on the […]
Shares of Revolution Medicines, Inc. (NASDAQ:RVMD – Get Free Report) have received an average rating of “Buy” from the twelve research firms that are currently covering the stock, MarketBeat reports. Twelve research analysts have rated the stock with a buy rating. The average 1-year target price among brokerages that have updated their coverage on the […]